JPH0432099Y2 - - Google Patents
Info
- Publication number
- JPH0432099Y2 JPH0432099Y2 JP1986179093U JP17909386U JPH0432099Y2 JP H0432099 Y2 JPH0432099 Y2 JP H0432099Y2 JP 1986179093 U JP1986179093 U JP 1986179093U JP 17909386 U JP17909386 U JP 17909386U JP H0432099 Y2 JPH0432099 Y2 JP H0432099Y2
- Authority
- JP
- Japan
- Prior art keywords
- container
- drug
- emergency
- release sheet
- bandage according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000003814 drug Substances 0.000 claims description 28
- 229940079593 drug Drugs 0.000 claims description 26
- 239000002775 capsule Substances 0.000 claims description 12
- 239000000853 adhesive Substances 0.000 claims description 8
- 230000001070 adhesive effect Effects 0.000 claims description 8
- 239000012528 membrane Substances 0.000 claims description 5
- 239000000919 ceramic Substances 0.000 claims description 3
- 229910052751 metal Inorganic materials 0.000 claims description 3
- 239000002184 metal Substances 0.000 claims description 3
- 229920003023 plastic Polymers 0.000 claims description 3
- 239000004033 plastic Substances 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 2
- 206010052428 Wound Diseases 0.000 description 7
- 208000027418 Wounds and injury Diseases 0.000 description 7
- 239000011248 coating agent Substances 0.000 description 7
- 238000000576 coating method Methods 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 239000000123 paper Substances 0.000 description 3
- 229920000742 Cotton Polymers 0.000 description 2
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 229920003002 synthetic resin Polymers 0.000 description 2
- 239000000057 synthetic resin Substances 0.000 description 2
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 1
- SIACJRVYIPXFKS-UHFFFAOYSA-N (4-sulfamoylphenyl)methylazanium;chloride Chemical compound Cl.NCC1=CC=C(S(N)(=O)=O)C=C1 SIACJRVYIPXFKS-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- CIVCELMLGDGMKZ-UHFFFAOYSA-N 2,4-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC(Cl)=C(C(O)=O)C(Cl)=N1 CIVCELMLGDGMKZ-UHFFFAOYSA-N 0.000 description 1
- OJFZXRZZXBFEAP-UHFFFAOYSA-N 5-chloro-1,6-dimethylcyclohexa-2,4-dien-1-ol Chemical compound ClC=1C(C(C=CC1)(C)O)C OJFZXRZZXBFEAP-UHFFFAOYSA-N 0.000 description 1
- IYLLULUTZPKQBW-UHFFFAOYSA-N Acrinol Chemical compound CC(O)C(O)=O.C1=C(N)C=CC2=C(N)C3=CC(OCC)=CC=C3N=C21 IYLLULUTZPKQBW-UHFFFAOYSA-N 0.000 description 1
- 229920000298 Cellophane Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 description 1
- ITRJWOMZKQRYTA-RFZYENFJSA-N Cortisone acetate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)COC(=O)C)(O)[C@@]1(C)CC2=O ITRJWOMZKQRYTA-RFZYENFJSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- HCBIBCJNVBAKAB-UHFFFAOYSA-N Procaine hydrochloride Chemical compound Cl.CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 HCBIBCJNVBAKAB-UHFFFAOYSA-N 0.000 description 1
- PPWHTZKZQNXVAE-UHFFFAOYSA-N Tetracaine hydrochloride Chemical compound Cl.CCCCNC1=CC=C(C(=O)OCCN(C)C)C=C1 PPWHTZKZQNXVAE-UHFFFAOYSA-N 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- RCYWWJBNPIWJMJ-UHFFFAOYSA-N [4-(hexadecanoyloxymethyl)-5-hydroxy-6-methylpyridin-3-yl]methyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC1=CN=C(C)C(O)=C1COC(=O)CCCCCCCCCCCCCCC RCYWWJBNPIWJMJ-UHFFFAOYSA-N 0.000 description 1
- MZVQCMJNVPIDEA-UHFFFAOYSA-N [CH2]CN(CC)CC Chemical group [CH2]CN(CC)CC MZVQCMJNVPIDEA-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940030225 antihemorrhagics Drugs 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 229960005274 benzocaine Drugs 0.000 description 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 229960002645 boric acid Drugs 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- 229940046978 chlorpheniramine maleate Drugs 0.000 description 1
- IVHBBMHQKZBJEU-UHFFFAOYSA-N cinchocaine hydrochloride Chemical compound [Cl-].C1=CC=CC2=NC(OCCCC)=CC(C(=O)NCC[NH+](CC)CC)=C21 IVHBBMHQKZBJEU-UHFFFAOYSA-N 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 229960003290 cortisone acetate Drugs 0.000 description 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 1
- 229960001378 dequalinium chloride Drugs 0.000 description 1
- LTNZEXKYNRNOGT-UHFFFAOYSA-N dequalinium chloride Chemical compound [Cl-].[Cl-].C1=CC=C2[N+](CCCCCCCCCC[N+]3=C4C=CC=CC4=C(N)C=C3C)=C(C)C=C(N)C2=C1 LTNZEXKYNRNOGT-UHFFFAOYSA-N 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003657 dexamethasone acetate Drugs 0.000 description 1
- 229940045574 dibucaine hydrochloride Drugs 0.000 description 1
- 229960000525 diphenhydramine hydrochloride Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 229960002179 ephedrine Drugs 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 239000011086 glassine Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 239000002874 hemostatic agent Substances 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- AHXDSVSZEZHDLV-UHFFFAOYSA-N mesulfen Chemical compound CC1=CC=C2SC3=CC(C)=CC=C3SC2=C1 AHXDSVSZEZHDLV-UHFFFAOYSA-N 0.000 description 1
- 229960005479 mesulfen Drugs 0.000 description 1
- 239000004081 narcotic agent Substances 0.000 description 1
- IAIWVQXQOWNYOU-FPYGCLRLSA-N nitrofural Chemical compound NC(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 IAIWVQXQOWNYOU-FPYGCLRLSA-N 0.000 description 1
- 229960001907 nitrofurazone Drugs 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
- 229960002800 prednisolone acetate Drugs 0.000 description 1
- 229960001309 procaine hydrochloride Drugs 0.000 description 1
- 229940095042 pyridoxine dipalmitate Drugs 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000003206 sterilizing agent Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 description 1
- YZMCKZRAOLZXAZ-UHFFFAOYSA-N sulfisomidine Chemical compound CC1=NC(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 YZMCKZRAOLZXAZ-UHFFFAOYSA-N 0.000 description 1
- 229960001975 sulfisomidine Drugs 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 229960002494 tetracaine hydrochloride Drugs 0.000 description 1
- 229920005992 thermoplastic resin Polymers 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- ICUTUKXCWQYESQ-UHFFFAOYSA-N triclocarban Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(Cl)C(Cl)=C1 ICUTUKXCWQYESQ-UHFFFAOYSA-N 0.000 description 1
- 229960001325 triclocarban Drugs 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 229960001296 zinc oxide Drugs 0.000 description 1
- 235000014692 zinc oxide Nutrition 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
Description
【考案の詳細な説明】 〔産業上の利用分野〕 本考案は救急絆創膏に関するものである。[Detailed explanation of the idea] [Industrial application field] This invention relates to an emergency bandage.
一般に繁用の簡易救急絆創膏は、殺菌消毒剤、
創傷治療剤を含浸させたガーゼを通気孔を有する
粘着性のシートに装着し、使用時に裏面の剥離紙
をはがして前記ガーゼ部を傷口局所に当てて使用
するようにしたものである。
Commonly used simple emergency bandages include sterilizing agents, disinfectants,
Gauze impregnated with a wound treatment agent is attached to an adhesive sheet with ventilation holes, and when used, the release paper on the back is peeled off and the gauze section is applied to the wound.
しかしながら、これらの従来品においては、予
めガーゼに薬液を含浸させておくため、経時的に
薬液が蒸散し、また効力の失活をきたすばかりで
なく、局所への当接に際してはガーゼ部が乾燥状
態となつているため、傷口をいためるおそれがあ
り、使用に際しても、痛みを感じさせる等の欠点
があつた。
However, in these conventional products, since the gauze is impregnated with the drug solution in advance, the drug solution evaporates over time and not only loses its effectiveness, but also causes the gauze part to dry when applied to the local area. Because of this condition, there was a risk of damaging the wound, and there were drawbacks such as making people feel pain when using it.
本考案は上記従来技術における問題点を解決す
るためのものであり、その目的とするところは薬
剤の効力を長期間保持することができ、且つ傷口
へ当接する際に傷口をいためることなく使用でき
る救急絆創膏を提供することにある。 The present invention is intended to solve the above-mentioned problems in the conventional technology, and its purpose is to maintain the efficacy of the drug for a long period of time, and to use it without damaging the wound when it comes into contact with the wound. The purpose is to provide emergency bandages.
〔問題点を解決するための手段〕
すなわち本考案の救急絆創膏は、パツドを装着
した粘着シートと薬剤を内包するコンテナーを有
する剥離シートと該コンテナー内に配置された独
立した粒状のコンテナー破壊体よりなることを特
徴とする。[Means for solving the problem] That is, the emergency bandage of the present invention consists of an adhesive sheet attached with a pad, a release sheet having a container containing a drug, and an independent granular container-destroying body disposed within the container. It is characterized by becoming.
又、本考案の好ましい実施態様としては以下の
ものが挙げられる。 Further, preferred embodiments of the present invention include the following.
（） コンテナーが剥離シートに形成された膨
出部とその開口部をシールする薬剤被覆膜で形
成されているもの。() The container is made of a bulge formed on a release sheet and a drug-coated membrane that seals the opening.
（） コンテナーが剥離シートと独立に形成さ
れたカプセル体であるもの。() The container is a capsule formed independently of the release sheet.
（） コンテナーが剥離シートと独立に形成さ
れ、開口部を薬剤被覆膜でシールされたカプセ
ル体であるもの。() A capsule body in which the container is formed independently of the release sheet and the opening is sealed with a drug-coated membrane.
（） コンテナーがPTP包装で形成されてい
るもの。() The container is made of PTP packaging.
（） コンテナー破壊体の形状が球状、半球
状、円錐状、角錐状、円錐台状、角錐台状又
は、これらの変形状のいずれかであるもの。() The shape of the container destroyer is spherical, hemispherical, conical, pyramidal, truncated cone, truncated pyramid, or any of these modified shapes.
（） コンテナー破壊体がプラスチツク製、セ
ラミツク製又は金属製であるもの。() Container-destroying bodies made of plastic, ceramic, or metal.
本考案の救急絆創膏に使用するコンテナー破壊
体は、防食性、耐薬品性を有するプラスチツク、
セラミツク、金属等により形成された任意の形状
物で、実質的に薬剤被覆膜又はカプセル体を破壊
できればよいが、形状としては例えば球状、半球
状、円錐状、角錐状、円錐台状、角錐台状又は、
これらの変形状のものが好ましい。又、その大き
さはコンテナー内に収納できるものであればよ
い。 The container destroyer used in the emergency bandage of the present invention is made of plastic, which has anti-corrosion and chemical resistance.
It may be any shape made of ceramic, metal, etc. as long as it can substantially destroy the drug coating film or capsule body, but the shape may be, for example, spherical, hemispherical, conical, pyramidal, truncated conical, or pyramidal. Table-shaped or
These modified shapes are preferred. Moreover, the size may be any size as long as it can be stored in the container.
本考案に使用する薬剤については、殺菌消毒剤
としてグルコン酸クロルヘキシジン、塩化ベンザ
ルコニウム、クロルキシレノール、アクリノー
ル、チアントール、塩化デカリニウム、スルフイ
ソミジン、スルフアミン、ニトロフラゾン、ホウ
酸、ホモスルフアミン、トリクロカルバン等があ
り、創傷部収斂治癒促進剤として酸化亜鉛、塩酸
ピリドキシン、酢酸トコフエロール、ジパルミチ
ン酸ピリドキシン等、止血剤として塩酸ナフアゾ
リン、硫酸亜鉛、塩酸エフエドリン等、抗炎症剤
としてはプレドニゾロン、デキサメサゾン、酢酸
コルチゾン等のステロイド剤、グリチルレチン、
塩化リゾチーム等、抗ヒスタミン剤としてマレイ
ン酸クロルフエニラミン、塩酸ジフエンヒドラミ
ン等がある。 The agents used in this invention include chlorhexidine gluconate, benzalkonium chloride, chlorxylenol, acrinol, thianthol, dequalinium chloride, sulfisomidine, sulfamine, nitrofurazone, boric acid, homosulfamine, triclocarban, etc. Astringent healing promoters include zinc oxide, pyridoxine hydrochloride, tocopherol acetate, pyridoxine dipalmitate, etc. Hemostatic agents include napazoline hydrochloride, zinc sulfate, and ephedrin hydrochloride; anti-inflammatory agents include steroids such as prednisolone, dexamethasone, and cortisone acetate; glycyrrhetin,
Examples of antihistamines include lysozyme chloride, chlorpheniramine maleate, diphenhydramine hydrochloride, and the like.
又、局麻剤としてはリドカイン、アミノ安息香
酸エチル、塩酸プロカイン、塩酸ジブカイン、塩
酸テトラカイン、塩酸パラブチルアミノ安息香酸
ジエチルアミノエチル等がある。 Local narcotics include lidocaine, ethyl aminobenzoate, procaine hydrochloride, dibucaine hydrochloride, tetracaine hydrochloride, diethylaminoethyl parabutylaminobenzoate hydrochloride, and the like.
これらの薬剤は目的に合わせ、単味で又は複数
の配合剤とすることができ、又、薬剤の性状は溶
液状の他、軟膏状、グリース状、粉末等流動性の
あるものであれば如何なる性状でもよい。 Depending on the purpose, these drugs can be used singly or as a combination of multiple drugs, and the drug may be in any fluid form, such as a solution, ointment, grease, or powder. It can also be a property.
粘着シートは、通常用いられるものでよく、パ
ツドは、脱脂綿その他各種の綿、不織布等を使用
することができ、適宜その中央部をへこませた形
状とすることができる。又、通常の方法により裏
面を防水処理してもよい。 The pressure-sensitive adhesive sheet may be one commonly used, and the pad may be made of absorbent cotton, various types of cotton, non-woven fabric, etc., and may be appropriately shaped with a concave central portion. Further, the back surface may be waterproofed by a conventional method.
剥離シートは、塩化ビニール樹脂その他の合成
樹脂、紙、又は合成樹脂と紙の貼り合せ物等の材
質により成型され、中央部に円形、だ円形若しく
は矩形状又はそれらの変形状のコンテナーを設
け、又剥離シートをめくり易くするために端部に
スリツトを設けるのがよい。コンテナーは剥離シ
ートに膨出部を形成し、又は剥離シートとは独立
に熱可塑性樹脂等でカプセル体を形成し、その開
口部を、薬剤を使用時までパツドに接触させるの
を防止するための薬剤被覆膜でシールしてもよ
く、あるいは単体のカプセル体として形成しても
よい。薬剤被覆膜はアルミ箔、グラシン紙、セロ
ハン等の材質で、前記剥離シートとPTP加工等
でシールされている。該被覆膜は、薬剤を保護し
うる大きさでよいが、粘着シートの下面全面に設
けられていてもさしつかえない。 The release sheet is molded from a material such as vinyl chloride resin or other synthetic resin, paper, or a combination of synthetic resin and paper, and has a circular, oval, or rectangular container in the center, or a container in a modified shape thereof, It is also preferable to provide a slit at the end of the release sheet to make it easier to turn over. The container has a bulge formed in the release sheet, or a capsule made of thermoplastic resin or the like independent of the release sheet, and the opening of the capsule is used to prevent the drug from coming into contact with the pad until the time of use. It may be sealed with a drug-coated membrane or formed as a single capsule body. The drug coating film is made of a material such as aluminum foil, glassine paper, or cellophane, and is sealed with the release sheet using PTP processing or the like. The coating film may be large enough to protect the drug, but may be provided on the entire lower surface of the pressure-sensitive adhesive sheet.
以下の実施例において本考案を更に詳細に説明
する。なお、本考案は下記実施例に限定されるも
のではない。
The invention will be explained in more detail in the following examples. Note that the present invention is not limited to the following examples.
実施例 １：
第１図に本考案の救急絆創膏の一実施例を示
す。本実施例ではコンテナー破壊体８として球状
のものを使用した。図中、他に１は粘着シート、
２はパツド、３は薬剤、４は剥離シート、５は薬
剤被覆膜、６はコンテナー、７はスリツトを示
す。Example 1: FIG. 1 shows an example of the emergency bandage of the present invention. In this embodiment, a spherical container destroyer 8 was used. In the figure, 1 is an adhesive sheet,
2 is a pad, 3 is a drug, 4 is a release sheet, 5 is a drug coating film, 6 is a container, and 7 is a slit.
本実施例の救急絆創膏を使用するに際しては、
コンテナー６を指で押圧してコンテナー破壊体８
により薬剤被覆膜５を破壊して、薬剤３をパツド
２上に流出させる。次いで、スリツト７を折り曲
げ剥離シート４を粘着シート１よりはがす。 When using the emergency bandage of this example,
Press the container 6 with your finger to destroy the container 8
The drug coating film 5 is destroyed and the drug 3 is caused to flow onto the pad 2. Next, the slit 7 is bent and the release sheet 4 is peeled off from the adhesive sheet 1.
実施例 ２：
第２図に本考案の別の実施例を示す。本実施例
ではコンテナー６はポリ塩化ビニル等で成形され
たカプセル体であり、剥離シート４に保持されて
いる。又、コンテナー破壊体８としては円錐状の
ものを用いた。Embodiment 2: FIG. 2 shows another embodiment of the present invention. In this embodiment, the container 6 is a capsule body made of polyvinyl chloride or the like, and is held by a release sheet 4. Further, as the container destroying body 8, a conical one was used.
実施例 ３：
第３図に本考案の別の実施例のカプセル体部分
を示す。本実施例ではカプセル体の開口部が薬剤
被覆膜５でシールされている。コンテナー破壊体
８としては半球状のものを用いた。Embodiment 3: FIG. 3 shows a capsule portion of another embodiment of the present invention. In this embodiment, the opening of the capsule body is sealed with a drug coating film 5. As the container destroyer 8, a hemispherical one was used.
第４図のａ乃至ｇに本考案の救急絆創膏に用い
るコンテナー破壊体の各種形状の例を示す。これ
らの１種又は２種以上を１個又は２個以上用いる
ことができる。 FIGS. 4a to 4g show examples of various shapes of the container destroyer used in the emergency bandage of the present invention. One or more of these may be used.
上述のように本考案の救急絆創膏は、パツドを
装着した粘着シートと薬剤を内包するコンテナー
を有する剥離シートと該コンテナー内に配置され
た独立した粒状のコンテナー破壊体よりなるもの
であるため、使用時、常に新鮮な薬剤の滲出した
パツドの部分を創傷面に当接使用することができ
るので、薬剤の効力を損ねることなく、又、傷口
をいためることなく使用することができる。さら
に、薬剤の効力を長期間保持できるので、殺菌、
消毒、治療の目的達成に有効である。さらに、本
考案の救急絆創膏においてはコンテナー破壊体が
独立した粒状であり、コンテナー内をある程度自
由に動くことができるため、救急絆創膏の保管時
や輸送時などの使用時以外の時にコンテナーに不
意の外力が加わつた場合においては、ある程度緩
衝作用が働く。このため、コンテナーが簡単に破
壊されることはないので保管時や輸送時の損傷が
防止され、保管や輸送が容易である。そして使用
時にはコンテナーが押圧されコンテナー破壊体の
動きが抑制されるので、容易にコンテナーを破壊
できる。又、種々の大きさや形状のコンテナーに
対しても同一のコンテナー破壊体を使用すること
ができるため、実用上都合が良い。
As mentioned above, the emergency bandage of the present invention consists of an adhesive sheet with a pad attached, a release sheet having a container containing a drug, and an independent granular container-destroying body placed inside the container, so it is easy to use. Since the part of the pad exuding fresh medicine can always be used in contact with the wound surface, the medicine can be used without impairing its effectiveness or damaging the wound. Furthermore, the efficacy of the drug can be maintained for a long period of time, allowing sterilization and
It is effective in achieving the purpose of disinfection and treatment. Furthermore, in the emergency bandage of the present invention, the container-destroying body is an independent granule and can move freely within the container to some extent, so there is no chance of the container being accidentally damaged when the emergency bandage is not in use, such as during storage or transportation. When external force is applied, a buffering effect works to some extent. Therefore, since the container is not easily destroyed, damage during storage and transportation is prevented, and storage and transportation are easy. When in use, the container is pressed and the movement of the container destroyer is suppressed, so the container can be easily destroyed. Furthermore, the same container destroyer can be used for containers of various sizes and shapes, which is convenient in practice.
第１図は本考案の救急絆創膏の一実施例の断面
図、第２図は本考案の別の実施例の断面図、第３
図は本考案の別の実施例のカプセル体部分の断面
図、第４図ａ乃至ｇは本考案の救急絆創膏に用い
る各種形状のコンテナー破壊体の斜視図である。
図中、１……粘着シート、２……パツド、３…
…薬剤、４……剥離シート、５……薬剤被覆膜、
６……コンテナー、７……スリツト、８……コン
テナー破壊体。
Fig. 1 is a cross-sectional view of one embodiment of the emergency bandage of the present invention, Fig. 2 is a cross-sectional view of another embodiment of the present invention, and Fig. 3 is a cross-sectional view of an embodiment of the emergency bandage of the present invention.
The figure is a sectional view of a capsule body portion of another embodiment of the present invention, and FIGS. 4a to 4g are perspective views of container destruction bodies of various shapes used for the emergency bandage of the present invention. In the figure, 1...adhesive sheet, 2...pad, 3...
...Drug, 4...Release sheet, 5...Drug coating film,
6...Container, 7...Slit, 8...Container destroyer.
Claims (1)
るコンテナーを有する剥離シートと該コンテナ
ー内に配置された独立した粒状のコンテナー破
壊体よりなることを特徴とする救急絆創膏。 (2) コンテナーが剥離シートに形成された膨出部
とその開口部をシールする薬剤被覆膜で形成さ
れていることを特徴とする実用新案登録請求の
範囲第１項記載の救急絆創膏。 (3) コンテナーが剥離シートと独立に形成された
カプセル体であることを特徴とする実用新案登
録請求の範囲第１項記載の救急絆創膏。 (4) コンテナーが剥離シートと独立に形成され、
開口部を薬剤被覆膜でシールされたカプセル体
であることを特徴とする実用新案登録請求の範
囲第１項記載の救急絆創膏。 (5) コンテナーがPTP包装で形成されているこ
とを特徴とする実用新案登録請求の範囲第１項
乃至第４項のうちのいずれか１項記載の救急絆
創膏。 (6) コンテナー破壊体の形状が球状、半球状、円
錐状、角錐状、円錐台状、角錐台状又は、これ
らの変形状のいずれかであることを特徴とする
実用新案登録請求の範囲第１項乃至第５項のう
ちのいずれか１項記載の救急絆創膏。 (7) コンテナー破壊体がプラスチツク製、セラミ
ツク製又は金属製であることを特徴とする実用
新案登録請求の範囲第１項乃至第６項のうちの
いずれか１項記載の救急絆創膏。[Scope of Claim for Utility Model Registration] (1) An emergency medical device comprising an adhesive sheet attached with a pad, a release sheet having a container containing a drug, and an independent granular container-destroying body disposed within the container. Bandaid. (2) The emergency bandage according to claim 1, wherein the container is formed of a bulge formed in a release sheet and a drug-coated membrane that seals the opening. (3) The emergency adhesive bandage according to claim 1, wherein the container is a capsule body formed independently of a release sheet. (4) The container is formed independently of the release sheet,
The emergency bandage according to claim 1, which is a capsule body whose opening is sealed with a drug-coated membrane. (5) The emergency bandage according to any one of claims 1 to 4 of the claims for utility model registration, characterized in that the container is formed of PTP packaging. (6) Utility model registration claim No. 1 characterized in that the shape of the container-destroying body is spherical, hemispherical, conical, pyramidal, truncated conical, truncated pyramidal, or any of these modified shapes. The emergency bandage according to any one of items 1 to 5. (7) The emergency bandage according to any one of claims 1 to 6 of the claims for utility model registration, characterized in that the container-destroying body is made of plastic, ceramic, or metal.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1986179093U JPH0432099Y2 (en) | 1986-11-21 | 1986-11-21 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1986179093U JPH0432099Y2 (en) | 1986-11-21 | 1986-11-21 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6385230U JPS6385230U (en) | 1988-06-03 |
| JPH0432099Y2 true JPH0432099Y2 (en) | 1992-07-31 |
Family
ID=31121841
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP1986179093U Expired JPH0432099Y2 (en) | 1986-11-21 | 1986-11-21 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0432099Y2 (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5892920U (en) * | 1981-12-14 | 1983-06-23 | 日本臓器製薬株式会社 | emergency bandage |
| JPS6063324U (en) * | 1983-10-08 | 1985-05-04 | 阿蘇製薬株式会社 | emergency bandage |
-
1986
- 1986-11-21 JP JP1986179093U patent/JPH0432099Y2/ja not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6385230U (en) | 1988-06-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR880003941Y1 (en) | First aid adhesive tape | |
| JP2513712B2 (en) | Wound dressing | |
| US4291697A (en) | Cleaning and application device for medical purposes | |
| US7048706B2 (en) | Hypoallergenic bandage | |
| WO2015188225A1 (en) | Wound dressing | |
| US4041946A (en) | Medicated member for pierced ears | |
| US3366112A (en) | Adhesive bandage having container of liquid medicament | |
| EP0297828A1 (en) | Novel medicated dressings | |
| US3297032A (en) | Adhesive bandage having container of medicament carried by removable protector strip | |
| US20120022474A1 (en) | Plaster with medication dispenser | |
| JPH0432099Y2 (en) | ||
| JPH0157580B2 (en) | ||
| JPH0534649Y2 (en) | ||
| WO2007048171A1 (en) | A medicated dressing for wound healing | |
| JPS61222451A (en) | Emergency bandage | |
| JPH0136519Y2 (en) | ||
| JP2004344389A (en) | Manufacturing method for wound protecting agent | |
| JPH0371900B2 (en) | ||
| KR880003940Y1 (en) | First aid adhesive tape | |
| JPH0479663B2 (en) | ||
| JPH0529463B2 (en) | ||
| CN212756480U (en) | Novel medicine storage type wound plaster and novel traditional Chinese medicine antibacterial wound plaster | |
| JPS63119764A (en) | Emergency adhesive plaster | |
| JP3099435U (en) | Wound protection plaster | |
| JP4136182B2 (en) | Emergency bandage |